News

Filter

1 to 9 of 43 results

AstraZeneca gets temporary injunction against Actavis over generic Pulmicort Respules

18-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that the US Court of Appeals for the…

ActavisAstraZenecaGenericsLegalPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Actavis launches generic Pulmicort Respules in USA

14-02-2015

Ireland-based generic drugs major Actavis has launched its generic version of Anglo-Swedish pharma major…

ActavisAstraZenecaGenericsLegalMarkets & MarketingPatentsPulmicort RespulesRespiratory and PulmonaryUSA

AstraZeneca acquires rights to Actavis’ branded respiratory portfolio in USA and Canada

AstraZeneca acquires rights to Actavis’ branded respiratory portfolio in USA and Canada

05-02-2015

Anglo-Swedish pharma major AstraZeneca has acquired the rights to Ireland-headquartered generics major…

ActavisAstraZenecaDalirespFinancialPharmaceuticalRespiratory and PulmonaryTudorza PressairUSA

Novartis reports top-line results in COPD trials; NDA acceptance will trigger milestone for Vectura

Novartis reports top-line results in COPD trials; NDA acceptance will trigger milestone for Vectura

08-01-2015

Swiss drug major Novartis today announced positive top-line results from the pivotal Phase III clinical…

MedicineNovartisPharmaceuticalQVA149ResearchRespiratory and PulmonaryUSAVecturaVectura Group

Meda and Cipla sue Apotex to enforce Dymista patents

Meda and Cipla sue Apotex to enforce Dymista patents

04-12-2014

Swedish pharma company Meda Pharmaceuticals and Indian drugmaker Cipla today have sued Canada-headquartered…

ApotexCiplaDymistaLegalMedaPharmaceuticalRespiratory and PulmonaryUSA

Asthma drug market set to grow $23 billion by 2023

28-11-2014

The asthma treatment market value will grow across eight major countries (the USA, UK, France, Germany,…

AdvairAstraZenecaAustraliaEuropeGlaxoSmithKlineJapanMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicortUSA

GlaxoSmithKline files for US and EU approval of mepolizumab

GlaxoSmithKline files for US and EU approval of mepolizumab

05-11-2014

UK pharma major GlaxoSmithKline says it has filed regulatory submissions in the USA and Europe for mepolizumab…

BarclaysBiotechnologyBosatriaEuropeGlaxoSmithKlineImmunosuppressantsmepolizumabRegulationRespiratory and PulmonaryUnited StatesUSA

US FDA approves Genentech’s Esbriet and Boehringer Ingelheim’s Ofev for IPF

US FDA approves Genentech’s Esbriet and Boehringer Ingelheim’s Ofev for IPF

16-10-2014

The US Food and Drug Administration has approved Esbriet (pirfenidone), from Roche subsidiary Genentech,…

Boehringer IngelheimEsbrietGenentechnintedanibPharmaceuticalRegulationRespiratory and PulmonaryUSA

1 to 9 of 43 results

COMPANY SPOTLIGHT

Menarini

Back to top